Featured Research

from universities, journals, and other organizations

New Defense Mechanism Against Intestinal Inflammation Found

Date:
March 15, 2008
Source:
McGill University Health Centre
Summary:
The body's first line of defense against pathogenic bacteria that we ingest may not be the immune system but rather the cells that line the intestine. This, and the various mechanisms revealed by this discovery, could lead to important therapeutic innovations, particularly in the treatment of diarrheal diseases and inflammatory bowel diseases such as Crohn's disease.

The body's first line of defence against pathogenic bacteria that we ingest may not be the immune system but rather the cells that line the intestine. This surprising conclusion is just one facet of a study by Dr. Maya Saleh, a researcher at the Research institute of the McGill University Health Centre that will be published in the journal Cell Host & Microbe on March 12.

Related Articles


This, and the various mechanisms revealed by this discovery, could lead to important therapeutic innovations, particularly in the treatment of diarrheal diseases and inflammatory bowel diseases such as Crohn's disease.

When pathogenic E. coli bacteria infect the body, they bind to epithelial cells on the interior wall of the intestine before injecting infectious material into the cells with a syringe-like mechanism. This contact triggers a defence reaction within the epithelial cell called the Nod pathway, which results in alerting the immune system as well as in the release of antimicrobial peptides called defensins.

Defensins act as antibiotics: they kill bacteria directly by puncturing holes in their walls. These peptides also play a role in activating the immune system itself and tuning the inflammatory reaction.

"This mechanism expands our idea of immunity: it hinges upon epithelial cells, not immune cells, early on during infection," says Dr. Saleh. "Furthermore, our study demonstrates that this mechanism is regulated negatively by the Caspase-12 protein, meaning that this protein limits defensin production. This hampers the elimination of bacteria, which then trigger an intense inflammatory reaction manifested by various symptoms including severe diahrrea."

These fundamental discoveries change our understanding of the immune defence. They also open new avenues for a deeper understanding and more targeted treatments of diseases related to intestinal inflammation, such as diarrheal diseases caused by pathogenic E. coli or Crohn's disease.

In the case of diarrhea, intestinal inflammation is caused by a process similar to the one described above by Dr. Saleh. Treatments that target Caspase-12 would decrease inflammation by acting on the source rather than on the symptoms.

Crohn's disease is the chronic inflammation of the digestive tract, and its specific causes are unknown. What is known, however, is that this pathology is linked to a genetic mutation in the Nod pathway. "This study allows us to consider three possible explanations for Crohn's disease: the Nod pathway mutation could induce either a lack of bacterial "sensing" or a hyperactivation of the immune system resulting in both cases in excessive inflammation against bacteria naturally present in the digestive system; it is also possible that the pathology is caused by an excessive and recurring reaction against a pathogenic microorganism," says Dr. Saleh. The debate is now open.

In each of these cases, medication targeting Caspase-12 would decrease inflammation symptoms by directly attacking the underlying cause.

Dr. Maya Saleh is a researcher with the Critical Care Division and the Centre for the Study of Host Resistance at the Research Institute of the McGill University Health Centre (MUHC) as well as an assistant professor with McGill University's Faculty of Medicine.

This study was funded by the Canadian Institutes for Health Research (CIHR) and the Canada Foundation for Innovation (CFI).


Story Source:

The above story is based on materials provided by McGill University Health Centre. Note: Materials may be edited for content and length.


Cite This Page:

McGill University Health Centre. "New Defense Mechanism Against Intestinal Inflammation Found." ScienceDaily. ScienceDaily, 15 March 2008. <www.sciencedaily.com/releases/2008/03/080312141253.htm>.
McGill University Health Centre. (2008, March 15). New Defense Mechanism Against Intestinal Inflammation Found. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2008/03/080312141253.htm
McGill University Health Centre. "New Defense Mechanism Against Intestinal Inflammation Found." ScienceDaily. www.sciencedaily.com/releases/2008/03/080312141253.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins